Conflicts of interest JE and ES have received financial support for parts of their research from Heidelberg Pharma, Almirall, Shire and Natlmmune. JE has acted as a paid consultant to Roche Diagnostics. ES has acted as a paid consultant to Meda, Mavig, Almirall, Spirig, Heidelberg Pharma, Intendis. CU has acted as a paid consultant to Almirall and Spirig. PMR and ML have no conflict of interest.
UV-induced squamous cell carcinoma – a role for antiapoptotic signalling pathways
Article first published online: 22 SEP 2009
© 2009 The Authors. Journal Compilation © 2009 British Association of Dermatologists
British Journal of Dermatology
Special Issue: Advances in the Management of UVR induced Skin Cancers.
Volume 161, Issue Supplement s3, pages 107–115, November 2009
How to Cite
Rodust, P.M., Stockfleth, E., Ulrich, C., Leverkus, M. and Eberle, J. (2009), UV-induced squamous cell carcinoma – a role for antiapoptotic signalling pathways. British Journal of Dermatology, 161: 107–115. doi: 10.1111/j.1365-2133.2009.09458.x
- Issue published online: 22 SEP 2009
- Article first published online: 22 SEP 2009
- Accepted for publication 7 August 2009
Options for accessing this content:
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.